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Introduction
The Netherlands is one of the smaller
European countries with approximately
16.5 million inhabitants. Paediatric ter-
tiarycare is centralized ineightuniversity
medical centres, while another 80 hos-
pitals taking care for children are spread
across the country. The time required
to travel to the closest hospital is within
60minutes formore than99 %of thepop-
ulation. Health care is provided free of
charge for children as they are covered by
their parents’ health insurance. Further-
more, schools are also free. The number
of private schools is very small. Uni-
versity fees are € 1,900 annually. Over-
all unemployment rates were approxi-
mately 7% in 2014, while young adult
(< 25 years) unemployment rates were
12%.
Paediatric care, and especially tertiary
care, is highly centralized (. Tab. 1). This
article focusses on the process of concen-
trating childhood cancer in the Nether-
lands.
Childhood cancer
Approximately 550 new cases of cancer
are diagnosed each year in the Nether-
lands. Many types of cancer occur less
Tab. 1 Examples of Dutch paediatric care centralization
Liver, small intestine, lung transplantation 1 centre
Bone marrow transplantation 2 centres
Kidney transplantation 3 centres
Cardiac surgery 4 centres
Oncology 7 centres
Paediatric intensive care 8 centres
Neonatal intensive care 10 centres
than 25 times per year. While cancer
is a frequent cause of death, the overall
survival rate is 75%. The distribution of
the diﬀerent types of childhood malig-
nancies is shown in . Fig. 1. For several
types of childhood cancer, the number of
patients seen at the present centres is low.
An example is shown in . Fig. 2, where
the prevalence of the paediatric patients
with solid tumours are presented for the
seven university medical centres in the
Netherlands. The largest, the Amster-
damMedicalCenter, hostsapproximately
30 children each year, while the smallest
centres treat lees than 10 patients each
year.
For several adult cancer types, there
is evidence that treatment in high-vol-
ume hospitals or by high case-volume
providers leads to a better outcome com-
pared with low-volume hospitals or low
case-volume providers [1, 2]. As an ex-
planation for thispositive correlation, the
“practice makes perfect” eﬀect has been
used; a greater supply of patients will give
physicians and their teams more experi-
ence and will consequently lead to im-
provement of care. Another explanation
of this volume eﬀect is the phenomenon
of selective referral, whichmeans aphysi-
cian or hospital with a reputation of ex-
cellent carewill attractmorepatients. Ina
recent review, Knops et al. provides sup-
port for thestatement thathigher-volume
hospitals, higher case-volume providers,
and specialised hospitals are related to
better outcomes in paediatric oncology
[3]. However, this is challenged in a
recent retrospective study from Switzer-
land [4]. Joseph et al. showed excellent
survival and morbidity rates in abdomi-
nal and thoracic paediatric solid-tumour
surgery in low volume centers.
Despite the contrasting data, paedi-
atric oncologists, together with a parent
paediatric oncology association in the
Netherlands, decided that all paediatric
cancer patients should be diagnosed in a
single centre. Following a bidding pro-
cess that caused a lot of collateral dam-
age, Utrecht was chosen to be that centre.
It was decided that the initial treatment
should be started there as well. Subse-
quent therapy could be provided in that
centre or in a limited number of other
hospitals.
So far, only abdominal and thoracic
solid-tumour treatments are centralized,
although patients with retinoblastoma
are treated in a single centre as well,
although not in Utrecht but in Ams-
terdam (VU University Medical Cen-




Despite the discussion on the presuppo-
sition that higher volume would result
in better outcome, most experts under-
line this statementwhenever surgical care
is involved. Other advantages include
the possibility of speciﬁc treatments for
small subsets of patients, where recog-
nition of rare deteriorations following
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Acute lymphoid leukemia (ALL), N=114
Acute myeloid leukemia (ALL), N=23





Aplastic Anemia/Fanconi Anemia, N=7
Ependymoma, N=12
Astrocytoma, N=47
Intracranial embryonal tumoar, N=23
Other glioma, N=16









Intracranial germ cell tumoar, N=6
Extracranial germ cell tumoar, N=12
Gonadal tumoar, N=12
Other solid tumoar, N=21
Fig. 18 Childhoodmalignancies in the Netherlands (2013).Data obtained from the DCOG registry
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Fig. 28 Prevalence of paediatric patients with solid tumours in theNetherlands (2013)
therapy might be noted earlier. Costs
and eﬃciency are mentioned as well. As
such, a centre hosts all national experts
andmay be attractive to international ex-
perts as well. Large numbers of patients
will be cared for and large international
multicentre research studies are likely to
be carried out at this centre. Training
and education can be developed easily,
as many types of care are centralized in
such a centre. Finally, this cancer hos-
pital may be considered an international
centre of reference, although that kind
of recognition will depend on the results
obtained.




are high as well. The costs of the new
paediatric cancer centre are estimated at
€ 190,000,000, while most Dutch oncol-
ogywards at thediﬀerentuniversitymed-
ical centres are already state of the art.
That implies a considerable amount of
wasted investments. Disturbances in re-
lations between professionals and par-
ents (loss of trust) or between healthcare
professionals themselves implies that pa-
tients and professionals will have to go
abroad to seek treatment or employment,
respectively. Interaction with the profes-
sionals who take care of adult patients
should be sought actively, whereas the
interaction occurs more naturally in the
present setting because of historical ties.
Training youngpaediatricianswill be dif-
ﬁcult as well. With a lack of exposure,
many paediatricians will be trained with-
out being in contact with children with
cancer. This can be solved, for example,
by 3-month internships, but this requires
the young doctors to move for that pe-
riod.
Centralized research
Obviously there are many advantages in
treating all paediatric patients at one hos-
pital. All patients can easily be asked
for consent. Eﬃciency and fundraising
possibilities will also be improved. In
spite of seeking sponsors in the region, a
national programme can be developed.
Disadvantages include a lack of national
competition for obtaining research fund-
ing and dominance by certain groups in
the ﬁeld of pediatric oncology research
as no competative groups are exisiting.
The Dutchmodel of centralized
paediatric oncology
We started earlier this year by bringing
all children with solid abdominal and
thoracic tumours to the Prinses Maxima
Centre in Utrecht, which is a depart-
mentof the children’shospital for thenext
3–4 years. Collaboration exists with the
existing paediatric oncology centres that
are currently treating more than 85% of
all paediatric oncology patients. The col-
laborationmeans that patients are treated
in shared care. The initial chemotherapy
and surgery occurs in Utrecht, but after
this, the children are treated alternately
at both Utrecht and a university hospi-
tal in the region of the family. It is also
possible to have shared care with a non-
university regional hospital.
Plans are being developed to organize
the care in a similar fashion for some but
not all other types of childhood cancer.
Within this model, the shared care is su-
pervised by the centre in Utrecht. This
process is cumbersome, as many stake-
holders are involved and improvement
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in care for a speciﬁc group should never
lead to deterioration of the quality of care
for another group. Also the transition
is a diﬃcult period, during which it is
diﬃcult to keep the quality of care at the
same level. New teams are being formed,
which inevitably requires some time to
adapt.
Aims
The aims are high. The board of the
Prinses Maxima Centre strives for a cure
rate of > 90% by 2025, with less than
half of the patients suﬀering from late
eﬀects of treatment. Those goals are am-
bitious, but certainly worth aiming for.
The future will tell whether this can (and
should) be reached through this kind of
centralization.
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Abstract
Paediatric tertiary care is highly centralized in
the Netherlands. The country is small (16 mil-
lion inhabitants, overall unemployment rates
were approximately 7% in 2014, while young
adult (< 25 years) unemployment rates were
12%) with the majority of the population
living in Amsterdam and Rotterdam and
their neighbouring cities/villages. There
are 90 hospitals taking care for children in
the Netherlands. Speciﬁc types of highly
specialized care, such as transplantation,
are provided in a maximum of three centres
(kidney transplants in 3, bone marrow
tranplants in 2, liver transplants in only one
center), while neonatal intensive care is
oﬀered in 10 hospitals. Recently, patients with
solid tumours in the thorax and abdomen
were concentrated in a single centre with ﬁve
university centres who provide care during
the less intensive part of the treatment (in
shared care). Similar changes are planned
for congenital surgery, aiming for two such
centres in the Netherlands. The general
view of the Dutch Paediatric Association
underscores the need for centralisation,while
high-level care should be guaranteed at
those hospitals where no specialized centre is
present.
Keywords
Paediatrics · Centralized care · Concentration
of care · Paediatric oncology · Netherlands
Bündelung der Krebsversorgung im Kindesalter in den
Niederlanden
Zusammenfassung
Die tertiäre Krankenversorgung für Kinder
ist stark zentralisiert in den Niederlanden.
Das Land ist klein (16 Mio. Einwohner, die
Arbeitslosenquote 2014 lag schätzungsweise
bei 7 %, unter jungen Erwachsenen
(< 25 Jahre) bei 12 %) und die Hälfte
der Bevölkerung lebt in Amsterdam und
Rotterdam sowie den benachbarten Städten
bzw. Dörfern. Fast 90 Krankenhäuser leisten
die stationäre Gesundheitsversorgung für
Kinder. Bestimmte Arten hochspezialisierter
Behandlungen wie Transplantationen
sind nur in höchstens drei Klinikzentren
verfügbar (Nierentransplantationen in 3,
Knochenmarktransplationen in 2, Lebertrans-
plantationennur in einemZentrum), während
z. B. die Neugeborenenintensivmedizin
in zehn Krankenhäusern angeboten wird.
Neuerdings werden Patientenmit soliden
Tumoren in Thorax und Abdomen in einem
einzigen Zentrum behandelt gemeinsam
mit 5 Universitätskliniken, die sich die
Versorgung während der weniger intensiven
Behandlungsperiode teilen. Für die Chirurgie
angeborener Fehlbildungen sind ähnliche
Veränderungen geplant. Es werden zwei
solcher Zentren für die Niederlande anvisiert.
Die niederländische Gesellschaft für Kinder-
und Jugendmedizin unterstreicht die
Notwendigkeit der Zentralisierung, während
die generelle Versorgung auf höchstem
fachlichem Niveau in den Krankenhäu-
sern garantiert sein sollte, welche keine
spezialisiertenZentren aufweisen.
Schlüsselwörter
Pädiatrie · Zentralisierte Gesund-
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